Market Overview

Global Structural Heart Devices Market to 2023: Opportunities in Percutaneous Interventions, Approval of TAVR for Extended Indications

Share:

Global Structural Heart Devices Market to 2023: Opportunities in Percutaneous Interventions, Approval of TAVR for Extended Indications

PR Newswire

DUBLIN, Sept. 13, 2018 /PRNewswire/ --

Research and Markets Logo. (PRNewsFoto/Research and Markets) (PRNewsfoto/Research and Markets)

The "Structural Heart Devices Market by Product (Heart Valve Devices (Transcatheter and Surgical), Occluders and Delivery Systems, Annuloplasty Rings, and Accessories), Procedure (Replacement and Repair) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2% during the forecast period.

The rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favorable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases are the major factors driving the growth of the structural heart devices market.

However, low affordability and inaccessibility of cardiac surgeries in developing countries are expected to restrain the growth of this market in the coming years. In addition, a dearth of skilled personnel may affect overall procedural volumes and serve to slow the pace of market growth during the forecast period.

The report describes and studies the global structural heart devices market, by product, procedure, and region. It provides detailed information regarding the major factors influencing the growth of this market and the regulatory analysis impacting market dynamics.

On the basis of product, the global structural heart devices market is segmented into heart valve devices, occluders and delivery systems, annuloplasty rings, other devices, and accessories. The heart valve devices segment is expected to register the highest CAGR during the forecast period. The high growth of this segment can be attributed to the growing number of transcatheter aortic valve replacement procedures performed across the globe, the efficacy and durability of these products, and the growing number of regulatory approvals for heart valve devices.

Based on procedure, the market is segmented into replacement procedures and repair procedures. The replacement procedures segment is further segmented into TAVR (transcatheter aortic valve replacement) procedures and SAVR (surgical aortic valve replacement) procedures, while the repair procedures segment is subdivided into closure procedures, annuloplasty, valvuloplasty, and TMVR procedures. The replacement procedures segment is expected to account for the largest market share in 2018 and is projected to register the highest CAGR during the forecast period. The growth in this segment can be attributed to the long-term durability of these procedures and the widespread preference for transcatheter replacement.

The geographic segments in this report include North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the structural heart devices market in 2018. The large share of this region in the global market is attributed to factors such as the rising prevalence of structural heart diseases, favorable reimbursement scenario for structural heart procedures and devices, technological advancements, and development of innovative devices.

The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such as the rising geriatric population, favorable reimbursement scenario, increasing regulatory approvals, the presence of a large target patient population, increasing healthcare expenditure, implementation of government-funded insurance schemes, and the growing medical tourism industry in several APAC countries are expected to drive the growth of the Asia Pacific structural heart devices market.

Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova PLC (UK) are the prominent players in the structural heart devices market.

The other players in this market include CryoLife, Inc. (US), Micro Interventional Devices, Inc. (US), Braile Biomdica (Brazil), Lepu Medical Technology (Beijing) Co., Ltd. (China), and TTK Healthcare Limited (India).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Structural Heart Devices: Market Overview
4.2 Geographic Analysis: Structural Heart Devices Market, By Repair Procedures
4.3 Structural Heart Devices Market, By Procedure, 2018 vs 2023
4.4 Structural Heart Devices Market, By Product, 2018 vs 2023
4.5 Geographic Snapshot of the Structural Heart Devices Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Structural Heart Diseases
5.2.1.2 Regulatory Approvals of New and Advanced Structural Heart Devices
5.2.1.2.1 Product Approvals for Medtronic
5.2.1.2.2 Product Approvals for Edwards Lifesciences Corporation
5.2.1.2.3 Product Approvals for Abbott Laboratories
5.2.1.2.4 Product Approvals for Livanova
5.2.1.2.5 Product Approvals for Micro Interventional Devices
5.2.1.3 Favorable Reimbursement Scenario
5.2.1.4 Increasing Awareness About Structural Heart Diseases
5.2.2 Restraints
5.2.2.1 Low Affordability and Inaccessibility of Cardiac Surgeries in Developing Countries
5.2.3 Opportunities
5.2.3.1 Percutaneous Interventions, Approval of TAVR for Extended Indications
5.2.3.2 Emerging Countries
5.2.3.3 Emergence of Tissue-Engineered Heart Valves
5.2.4 Challenges
5.2.4.1 Dearth of Skilled Personnel

6 Structural Heart Devices Market, By Product
6.1 Introduction
6.2 Heart Valve Devices
6.2.1 Transcatheter Heart Valves
6.2.2 Surgical Heart Valves
6.2.2.1 Tissue Heart Valves
6.2.2.2 Mechanical Heart Valves
6.3 Occluders & Delivery Systems
6.4 Annuloplasty Rings
6.5 Accessories
6.6 Other Devices

7 Structural Heart Devices Market, By Procedure
7.1 Introduction
7.1.1 Replacement Procedures
7.1.1.1 TAVR Procedures
7.1.1.2 Savr Procedures
7.1.2 Repair Procedures
7.1.2.1 Closure Procedures
7.1.2.2 Annuloplasty
7.1.2.3 Valvuloplasty
7.1.2.4 TMVR Procedures

8 Structural Heart Devices Market, By Region
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 Italy
8.3.3 UK
8.3.4 France
8.3.5 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World

9 Competitive Landscape
9.1 Overview
9.2 Market Ranking Analysis of Key Players, 2017
9.3 Competitive Scenario
9.3.1 Product Launches and Approvals
9.3.2 Acquisitions
9.3.3 Expansions
9.3.4 Partnerships and Agreements

10 Company Profiles

For more information about this report visit

https://www.researchandmarkets.com/research/5grghn/global_structural?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/global-structural-heart-devices-market-to-2023-opportunities-in-percutaneous-interventions-approval-of-tavr-for-extended-indications-300712330.html

SOURCE Research and Markets

View Comments and Join the Discussion!